Norepinephrine has long been the stable pressor agent for sepsis, but new data suggest that vasopressin might offer unique benefits. In this “150 Second Analysis”, MedPage Today clinical reviewer F. Perry Wilson discusses a study pitting the two drugs head-to-head, with an eye on renal failure as the primary outcome.
F. Perry Wilson, MD, MSCE, is an assistant professor of medicine at the Yale School of Medicine. He earned his BA from Harvard University, graduating with honors with a degree in biochemistry. He then attended Columbia College of Physicians and Surgeons in New York City. From there he moved to Philadelphia to complete his internal medicine residency and nephrology fellowship at the Hospital of the University of Pennsylvania. During his post graduate years, he also obtained a Master of Science in Clinical Epidemiology from the University of Pennsylvania. He is an accomplished author of many scientific articles and holds several NIH grants. He is a MedPage Today reviewer, and in addition to his video analyses, he authors a blog, The Methods Man. You can follow @methodsmanmd on Twitter.
Also visit the link to view the video: